These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22074437)

  • 1. Statin discontinuation in high-risk patients: a systematic review of the evidence.
    Gomez Sandoval YH; Braganza MV; Daskalopoulou SS
    Curr Pharm Des; 2011 Nov; 17(33):3669-89. PubMed ID: 22074437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of perioperative statin therapy for noncardiac surgery.
    Skrlin S; Hou V
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin treatment non-adherence and discontinuation: clinical implications and potential solutions.
    Phan K; Gomez YH; Elbaz L; Daskalopoulou SS
    Curr Pharm Des; 2014; 20(40):6314-24. PubMed ID: 24953391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
    Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
    Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-adherence to statin therapy: a major challenge for preventive cardiology.
    Bates TR; Connaughton VM; Watts GF
    Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement.
    Banach M; Stulc T; Dent R; Toth PP
    Int J Cardiol; 2016 Dec; 225():184-196. PubMed ID: 27728862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality.
    Liberopoulos EN; Florentin M; Mikhailidis DP; Elisaf MS
    Expert Opin Drug Saf; 2008 Nov; 7(6):717-25. PubMed ID: 18983218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: A systematic review and meta-analysis.
    Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2470-2482. PubMed ID: 36064686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review.
    Ageeb SA; Abdelmoghith A; ElGeed H; Awaisu A; ElMansor A; Owusu YB
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5879. PubMed ID: 39135516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanistic and clinical implications concerning the safety of statin discontinuation.
    Jasińska-Stroschein M; Owczarek J; Wejman I; Orszulak-Michalak D
    Pharmacol Rep; 2011; 63(4):867-79. PubMed ID: 22001974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Reston JT; Buelt A; Donahue MP; Neubauer B; Vagichev E; McShea K
    Ann Intern Med; 2020 Nov; 173(10):806-812. PubMed ID: 32956601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.
    Hope HF; Binkley GM; Fenton S; Kitas GD; Verstappen SMM; Symmons DPM
    PLoS One; 2019; 14(1):e0201196. PubMed ID: 30653535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.
    de Vries FM; Kolthof J; Postma MJ; Denig P; Hak E
    PLoS One; 2014; 9(11):e111247. PubMed ID: 25372483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonstatin therapies for management of dyslipidemia: a review.
    Sando KR; Knight M
    Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.
    De Vera MA; Bhole V; Burns LC; Lacaille D
    Br J Clin Pharmacol; 2014 Oct; 78(4):684-98. PubMed ID: 25364801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of Statins: What Are the Risks?
    Marrs JC; Kostoff MD
    Curr Atheroscler Rep; 2016 Jul; 18(7):41. PubMed ID: 27221503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.